Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - Uniqa, Do&Co, Marinomed, Palfinger (18/02/2021)

21.02.2021

Uniqa: Contrary to initial expectations of potentially negative earnings as laid out in preliminary work on financial statements, Uniqa Insurance Group's earnings before taxes for the 2020 financial year are expected to come to Euro 57.1 mn. The plan to possibly not distribute a dividend for the 2020 financial year is being revised in light of expected earnings and the insider information published on 14 April 2020 updated accordingly. Taking account of statements by the European Insurance and Occupational Pensions Authority (EIOPA) and the Austrian Financial Market Supervisory Authority, the Management Board of Uniqa Insurance Group AG - after consultation with the Supervisory Board - intend to propose a dividend of Euro 0.18 per share to the Annual General Meeting on 31 May 2021.
Uniqa: weekly performance: 1.89%

Do&Co: In the first three quarters of the business year 2020/2021, catering company Do & Co Group recorded revenue in the amount of Euro 189.91 mn, representing a decrease of -75.0% or € -569.97m on the previous year. Consolidated earnings before interest and tax (EBIT) of the DO & CO Group amounted to Euro -24.91 mn for the first three quarters of the business year 2020/2021, Euro -73.88 mn lower than in the same period of the previous year. The net result decreased by Euro -56.97 mn from Euro 21.42 mn in the previous year to Euro -35.55 mn in the first three quarters of the business year 2020/2021. The decline in revenue and in the result is solely and exclusively attributable to the impact of the Covid-19 pandemic. In all its divisions and its different markets, Do & Co emphasized that is well prepared for market openings owing to its existing business model as well as newly developed products, and hopes for an excellent market positioning in all segments. The acquisition of new major customers such as Delta Air Lines in Detroit or Jet Blue in Los Angeles, San Diego and Palm Springs or the intensification of business relations with Qatar Airways and Etihad show that Do & Co continues to offer a highly competitive product portfolio that is particularly well received by quality-focused customers even during the crisis.
DO&CO: weekly performance: 5.62%

Marinomed: Marinomed Biotech AG, a globally operating biopharmaceutical company, announced today that further data on the efficacy of Carragelose® in preventing SARS-CoV-2 infection in vitro have been published in the renowned peer-reviewed journal Plos ONE. The study conducted by Prof. Ulrich Schubert and his team at the Institute of Virology, Friedrich-Alexander University Erlangen-Nuremberg, Germany and Marinomed Biotech AG, Vienna, Austria, confirms previous studies showing effective inhibition of SARS-CoV-2 replication in vitro. “Our findings show very clearly that Carragelose can effectively neutralize SARS-CoV-2 in vitro, preventing the virus from infecting further cells,” said Schubert from the Institute of Virology, Friedrich-Alexander University Erlangen-Nuremberg, Germany and Marinomed’s cooperation partner. “Similar in vitro results previously obtained with other respiratory viruses like Influenza Type A and older Coronaviruses were translated into clinical efficacy as shown in four clinical studies that confirmed a reduction of both duration and severeness of symptoms. We believe this will hold true also for SARS-CoV-2.” The Plos ONE publication shows that the active ingredient Carragelose, the sulfated polymer iota-carrageenan, has antiviral activity against both wild-type SARS-CoV-2 and SARS-CoV-2 spike protein pseudotyped lentivirus, a harmless virus designed to look like and attach to cells like SARS-CoV-2 but which cannot cause COVID-19.
Marinomed Biotech: weekly performance: 17.65%

Palfinger: Palfinger, provider of lifting solution systems, has successfully ramped up production after a Cyberattack. "We are very happy that we have returned to normal operations. The last few weeks have been very challenging and thanks to the tireless efforts of all our employees, we have once again proven the strength that lies within our company," says CEO Andreas Klauser. In order to resume production and sales as quickly as possible and to ensure planning security for its customers and partners, Palfinger has made use of all available options. Therefore, system recovery efforts were successfully implemented with all speed. "Finally, we can fully concentrate again on what we do best: developing and producing innovative and reliable crane and lifting solutions. Overall, we are emerging stronger from the cyber-attack," adds CEO Klauser optimistically. "All 35 Palfinger production sites are running at full speed. We would like to take this opportunity to also thank our customers and business partners, who have supported us energetically during this challenging time - now we can really hit the ground running again," says CEO Andreas Klauser. "Our highly standardized and centrally operated IT infrastructure enabled us to get a grip on this complex situation quickly and efficiently. We have also implemented optimizations of our IT security in the last few weeks in a very short time and earlier than previously planned. We continue to pursue the path of constant further development and standardization of our IT systems, which ensures IT security and reliability in the operating and business processes at a high level,” adds CFO Felix Strohbichler.
Palfinger: weekly performance: -2.85%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (18/02/2021)


Partners









latest 21st Austria

21st Austria weekly - Uniqa, Do&Co, Marinomed, Palfinger (18/02/2021)


21.02.2021


Uniqa: Contrary to initial expectations of potentially negative earnings as laid out in preliminary work on financial statements, Uniqa Insurance Group's earnings before taxes for the 2020 financial year are expected to come to Euro 57.1 mn. The plan to possibly not distribute a dividend for the 2020 financial year is being revised in light of expected earnings and the insider information published on 14 April 2020 updated accordingly. Taking account of statements by the European Insurance and Occupational Pensions Authority (EIOPA) and the Austrian Financial Market Supervisory Authority, the Management Board of Uniqa Insurance Group AG - after consultation with the Supervisory Board - intend to propose a dividend of Euro 0.18 per share to the Annual General Meeting on 31 May 2021.
Uniqa: weekly performance: 1.89%

Do&Co: In the first three quarters of the business year 2020/2021, catering company Do & Co Group recorded revenue in the amount of Euro 189.91 mn, representing a decrease of -75.0% or € -569.97m on the previous year. Consolidated earnings before interest and tax (EBIT) of the DO & CO Group amounted to Euro -24.91 mn for the first three quarters of the business year 2020/2021, Euro -73.88 mn lower than in the same period of the previous year. The net result decreased by Euro -56.97 mn from Euro 21.42 mn in the previous year to Euro -35.55 mn in the first three quarters of the business year 2020/2021. The decline in revenue and in the result is solely and exclusively attributable to the impact of the Covid-19 pandemic. In all its divisions and its different markets, Do & Co emphasized that is well prepared for market openings owing to its existing business model as well as newly developed products, and hopes for an excellent market positioning in all segments. The acquisition of new major customers such as Delta Air Lines in Detroit or Jet Blue in Los Angeles, San Diego and Palm Springs or the intensification of business relations with Qatar Airways and Etihad show that Do & Co continues to offer a highly competitive product portfolio that is particularly well received by quality-focused customers even during the crisis.
DO&CO: weekly performance: 5.62%

Marinomed: Marinomed Biotech AG, a globally operating biopharmaceutical company, announced today that further data on the efficacy of Carragelose® in preventing SARS-CoV-2 infection in vitro have been published in the renowned peer-reviewed journal Plos ONE. The study conducted by Prof. Ulrich Schubert and his team at the Institute of Virology, Friedrich-Alexander University Erlangen-Nuremberg, Germany and Marinomed Biotech AG, Vienna, Austria, confirms previous studies showing effective inhibition of SARS-CoV-2 replication in vitro. “Our findings show very clearly that Carragelose can effectively neutralize SARS-CoV-2 in vitro, preventing the virus from infecting further cells,” said Schubert from the Institute of Virology, Friedrich-Alexander University Erlangen-Nuremberg, Germany and Marinomed’s cooperation partner. “Similar in vitro results previously obtained with other respiratory viruses like Influenza Type A and older Coronaviruses were translated into clinical efficacy as shown in four clinical studies that confirmed a reduction of both duration and severeness of symptoms. We believe this will hold true also for SARS-CoV-2.” The Plos ONE publication shows that the active ingredient Carragelose, the sulfated polymer iota-carrageenan, has antiviral activity against both wild-type SARS-CoV-2 and SARS-CoV-2 spike protein pseudotyped lentivirus, a harmless virus designed to look like and attach to cells like SARS-CoV-2 but which cannot cause COVID-19.
Marinomed Biotech: weekly performance: 17.65%

Palfinger: Palfinger, provider of lifting solution systems, has successfully ramped up production after a Cyberattack. "We are very happy that we have returned to normal operations. The last few weeks have been very challenging and thanks to the tireless efforts of all our employees, we have once again proven the strength that lies within our company," says CEO Andreas Klauser. In order to resume production and sales as quickly as possible and to ensure planning security for its customers and partners, Palfinger has made use of all available options. Therefore, system recovery efforts were successfully implemented with all speed. "Finally, we can fully concentrate again on what we do best: developing and producing innovative and reliable crane and lifting solutions. Overall, we are emerging stronger from the cyber-attack," adds CEO Klauser optimistically. "All 35 Palfinger production sites are running at full speed. We would like to take this opportunity to also thank our customers and business partners, who have supported us energetically during this challenging time - now we can really hit the ground running again," says CEO Andreas Klauser. "Our highly standardized and centrally operated IT infrastructure enabled us to get a grip on this complex situation quickly and efficiently. We have also implemented optimizations of our IT security in the last few weeks in a very short time and earlier than previously planned. We continue to pursue the path of constant further development and standardization of our IT systems, which ensures IT security and reliability in the operating and business processes at a high level,” adds CFO Felix Strohbichler.
Palfinger: weekly performance: -2.85%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (18/02/2021)




 

Bildnachweis

Aktien auf dem Radar:Marinomed Biotech, Frequentis, Zumtobel, Warimpex, Amag, CA Immo, Strabag, ATX, ATX Prime, ATX TR, Wolford, Bawag, Flughafen Wien, RBI, OMV, Addiko Bank, EVN, AB Effectenbeteiligungen , AMS, Cleen Energy, Pierer Mobility AG, Rosenbauer, Oberbank AG Stamm, Österreichische Post, voestalpine, Polytec Group.


Random Partner

KTM
Die KTM Industries-Gruppe ist eine europäische Fahrzeug-Gruppe mit dem strategischen Fokus auf das globale Sportmotorradsegment und den automotiven high-tech Komponentenbereich. Mit ihren weltweit bekannten Marken KTM, Husqvarna Motorcycles, WP und Pankl zählt sie in ihren Segmenten jeweils zu den Technologie- und Marktführern.

>> Besuchen Sie 60 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten